Scott Henry
Stock Analyst at Alliance Global Partners
(1.26)
# 3,692
Out of 5,090 analysts
51
Total ratings
37.74%
Success rate
-5.37%
Average return
Main Sectors:
Stocks Rated by Scott Henry
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TNON Tenon Medical | Initiates: Buy | $3 | $1.11 | +170.27% | 1 | Apr 9, 2025 | |
| QSI Quantum-Si incorporated | Initiates: Buy | $3.75 | $1.44 | +160.42% | 1 | Feb 7, 2025 | |
| VVOS Vivos Therapeutics | Maintains: Buy | $8.25 → $6 | $2.07 | +189.86% | 4 | Nov 19, 2024 | |
| LPCN Lipocine | Initiates: Buy | $10 | $3.15 | +217.46% | 1 | Sep 24, 2024 | |
| ASRT Assertio Holdings | Initiates: Buy | $2.75 | $0.77 | +258.31% | 1 | May 28, 2024 | |
| DERM Journey Medical | Initiates: Buy | $8.5 | $7.93 | +7.19% | 2 | Feb 16, 2024 | |
| RNXT RenovoRx | Initiates: Buy | $4 | $0.94 | +324.94% | 3 | Feb 2, 2024 | |
| FBIO Fortress Biotech | Maintains: Buy | $30 → $15 | $2.83 | +430.04% | 2 | Nov 29, 2023 | |
| RVPH Reviva Pharmaceuticals Holdings | Reiterates: Buy | $12 | $0.62 | +1,847.74% | 2 | Oct 30, 2023 | |
| CSBR Champions Oncology | Maintains: Buy | $9 → $7.5 | $6.04 | +24.17% | 2 | Sep 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $13 | $9.78 | +32.92% | 4 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $24 | $38.55 | -37.74% | 2 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $10 → $16 | $23.53 | -34.13% | 2 | Aug 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $55 → $58 | $84.53 | -31.39% | 6 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $36 | $94.57 | -61.93% | 1 | Aug 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $11 | $0.94 | +1,069.84% | 3 | May 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $6 | $3.90 | +53.85% | 2 | Feb 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6,000 → $5,750 | $1.43 | +401,997.90% | 1 | Feb 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.68 | - | 1 | Dec 4, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $7 | $1.04 | +573.08% | 3 | Nov 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $19.64 | - | 5 | Apr 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.21 | - | 2 | Mar 26, 2018 |
Tenon Medical
Apr 9, 2025
Initiates: Buy
Price Target: $3
Current: $1.11
Upside: +170.27%
Quantum-Si incorporated
Feb 7, 2025
Initiates: Buy
Price Target: $3.75
Current: $1.44
Upside: +160.42%
Vivos Therapeutics
Nov 19, 2024
Maintains: Buy
Price Target: $8.25 → $6
Current: $2.07
Upside: +189.86%
Lipocine
Sep 24, 2024
Initiates: Buy
Price Target: $10
Current: $3.15
Upside: +217.46%
Assertio Holdings
May 28, 2024
Initiates: Buy
Price Target: $2.75
Current: $0.77
Upside: +258.31%
Journey Medical
Feb 16, 2024
Initiates: Buy
Price Target: $8.5
Current: $7.93
Upside: +7.19%
RenovoRx
Feb 2, 2024
Initiates: Buy
Price Target: $4
Current: $0.94
Upside: +324.94%
Fortress Biotech
Nov 29, 2023
Maintains: Buy
Price Target: $30 → $15
Current: $2.83
Upside: +430.04%
Reviva Pharmaceuticals Holdings
Oct 30, 2023
Reiterates: Buy
Price Target: $12
Current: $0.62
Upside: +1,847.74%
Champions Oncology
Sep 22, 2023
Maintains: Buy
Price Target: $9 → $7.5
Current: $6.04
Upside: +24.17%
Aug 16, 2023
Maintains: Buy
Price Target: $10 → $13
Current: $9.78
Upside: +32.92%
May 3, 2023
Maintains: Buy
Price Target: $19 → $24
Current: $38.55
Upside: -37.74%
Aug 24, 2022
Downgrades: Neutral
Price Target: $10 → $16
Current: $23.53
Upside: -34.13%
Aug 3, 2021
Maintains: Neutral
Price Target: $55 → $58
Current: $84.53
Upside: -31.39%
Aug 2, 2021
Maintains: Buy
Price Target: $32 → $36
Current: $94.57
Upside: -61.93%
May 12, 2021
Maintains: Buy
Price Target: $9 → $11
Current: $0.94
Upside: +1,069.84%
Feb 26, 2021
Maintains: Buy
Price Target: $4 → $6
Current: $3.90
Upside: +53.85%
Feb 16, 2021
Maintains: Buy
Price Target: $6,000 → $5,750
Current: $1.43
Upside: +401,997.90%
Dec 4, 2020
Downgrades: Neutral
Price Target: n/a
Current: $1.68
Upside: -
Nov 11, 2020
Upgrades: Buy
Price Target: $7
Current: $1.04
Upside: +573.08%
Apr 18, 2019
Upgrades: Buy
Price Target: n/a
Current: $19.64
Upside: -
Mar 26, 2018
Downgrades: Neutral
Price Target: n/a
Current: $1.21
Upside: -